Immunogen inc

Major-Pharmaceuticals

IMGN


830 Winter Street
Waltham , MA 02451

Executive/
Director

Price

  • Last Close
  • $ 31.23
    $ +0 0 %
    Feb 9, 2024
  • 52-Week High/Low
  • $31.23 - $12.46
  • YTD
  • 0%

  • Trading Volume
  • 48,606,862
  • Market Cap Full
  • $ 8.3B
  • Shares Outstanding
  • 266.3M
    Oct 25, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -37.2% 89.7% 64.1% -43.5% -5% 26% -35.9% -22.6% 5.3% -
Q2 -63.9% 83.7% -4.5% -12.4% 4% -19.3% -5.5% 391.4% - -
Q3 -13% 7.6% -7% 11.3% 8% -14% 6.2% -15.9% - -
Q4 -23.9% -19.1% -48.2% 102.3% 75.4% 30.9% 3.8% 88% - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 -1.1% 6.5% - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    122%-85%214%-25%7%26%15%-33%498%5%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.37 0.20 -0.3 -0.3 -0.17 -0.17 -0.1 -0.16
Q2 0.51 0.10 -0.31 -0.29 -0.14 -0.15 -0.24 -0.02
Q3 0.46 0.37 -0.32 -0.15 -0.13 -0.18 -0.31 0.10
Q4 0.39 0.10 -0.28 0.04 0.19 -0.18 -0.23 -
A 1.7 0.8 -1.2 -0.7 -0.3 -0.7 -0.9 -0.08

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 149.4 174.3 199.7 220.5 226
Jun 133 149.5 174.4 199.9 220.5 226.1
Sep 149 149.9 174.5 201.6 220.7 248.9
Dec 149.1 149.7 187.5 202.6 220.8 266.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 6.1 0.1 7.8 7.5 3.1
Total Asset Turnover 0.3 - 0.4 0.4 0.2
Leverage
Interest Coverage -110.5 - -1 -7.7 -20.1
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Equity multiplier 0.1 - 0.2 -0.1 1.6